← Every applicant
Nivagen FDA Approvals
6 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| ZINC SULFATENew drugJul 5, 2024SOLUTION, INTRAVENOUS |
| REMIFENTANIL HYDROCHLORIDENew drugJun 28, 2024INJECTABLE, INJECTION |
| NEOSTIGMINE METHYLSULFATENew drugNov 3, 2022SOLUTION, INTRAVENOUS |
| CALCIUM GLUCONATENew drugOct 14, 2022SOLUTION, INTRAVENOUS |
| TEMOZOLOMIDENew drugNov 23, 2021CAPSULE, ORAL |
| GLYCOPYRROLATENew drugOct 13, 2021INJECTABLE, INJECTION |